Abbott Initiates Clinical Trial of Absorbâ„¢ in the United States

[at noodls] – Abbott Park, lllinois (NYSE: ABT) – Abbott announced today the initiation of the ABSORB III clinical trial in patients in the United States. This randomized, controlled trial is designed to enroll approximately … more

View todays social media effects on ABT

View the latest stocks trending across Twitter. Click to view dashboard

See who Abbott is hiring next, click here to view